Vice President, Competitive Intelligence & Strategic Foresight

Bristol Myers Squibb • Princeton, NJ

23h • Hybrid

About The Position

The Vice President, Competitive Intelligence & Strategic Foresight is a senior, enterprise‑facing leader in Portfolio Strategy, accountable for strengthening Bristol Myers Squibb’s understanding of the global competitive environment across oncology, hematology, neuroscience, immunology, and cardiovascular. This leader sets the vision, operating model, and standards for how next‑generation intelligence and foresight are generated, synthesized, and applied—translating complex, multi‑source signals into clear implications and decisions that shape pipeline, portfolio, commercial strategy, launch planning, and business development. As a trusted advisor to senior leaders, this role leads a globally distributed CI and foresight organization and ensures insights are proactively embedded in key enterprise and Therapeutic Area decisions, with initial emphasis on advancing enterprise impact through a clear service model, modernizing CI through AI‑enabled capabilities, and scaling impact through standardized methods, reusable products, and self‑service tools for TA teams and enterprise‑wide ways of working. The Vice President will set and sustain a high bar for executive‑ready products, strengthen governance and stakeholder partnerships, and foster a rigorous, ethical intelligence culture, with accountability for the continued maturation and evolution of CI and foresight as a core enterprise capability, ensuring sustained relevance and impact as strategy, portfolio priorities, and the external environment evolve.

Requirements

• Advanced degree required: M.S., Ph.D., Pharm.D., or M.D. in a life sciences discipline, or an MBA from a top-tier institution with a strong scientific foundation.
• 15+ years of progressive experience in competitive intelligence, strategic market insights, corporate strategy, or management consulting, including significant biopharmaceutical experience.
• 7+ years of people leadership experience, including leading global teams and influencing senior stakeholders.
• Demonstrated track record of influencing high-stakes decisions (e.g., pipeline investments, launch strategy, and business development) through rigorous, decision-ready competitive intelligence.
• Deep therapeutic area expertise in one or more of BMS’s core areas: oncology, hematology, neuroscience, immunology, or cardiovascular.
• Mastery of qualitative and quantitative CI methods, including primary and secondary research, win/loss analysis, scenario planning, and competitive benchmarking.
• Strong command of CI platforms and data sources (e.g., Evaluate Pharma, IQVIA, GlobalData, Citeline, PubMed, SEC filings, clinical trial registries)
• Proficiency in advanced analytics, data visualization, and executive storytelling.
• Exceptional ability to synthesize ambiguity into clear implications, options, and recommendations.
• Proven ability to influence and advise senior leaders with credibility and clarity.
• Demonstrated success driving alignment in highly matrixed, global organizations.
• Outstanding written, verbal, and visual communication; able to deliver a compelling, evidence-based narrative.
• Proven ability to modernize capabilities, implement new operating models, and build strong executive alignment and trust through measurable impact.
• Deep understanding of and commitment to legal and ethical boundaries governing competitive intelligence collection and use.
• Ability to thrive in a fast-paced, rapidly evolving competitive environment with multiple simultaneous priorities.

Nice To Haves

• Dual credentials (e.g., Ph.D. + MBA) are a strong differentiator
• Prior experience in a VP-level or equivalent senior strategic leadership role within biopharma or a top-tier healthcare consultancy strongly preferred

Responsibilities

• Define and champion the long-term global vision, operating model, and standards for Competitive Intelligence (CI) & Strategic Foresight, aligned to BMS enterprise strategy and growth objectives.
• Embed competitive and foresight insights into TA and Disease Area strategies, enterprise portfolio tradeoffs, and program-level investment decisions—ensuring intelligence is decision-integrated and action-oriented.
• Serve as a trusted thought partner to the BMS Leadership Team, Enterprise Strategy Office, Therapeutic Area leadership, and the Board on competitive dynamics, market inflection points, and strategic risks and opportunities.
• Set a modernization agenda that advances BMS toward best-in-class, AI-enabled CI capabilities and measurable enterprise impact.
• Lead the end-to-end design and delivery of rigorous, ethically sourced competitive intelligence covering competitor pipelines, clinical development, launches, pricing and market access strategies, and digital engagement approaches.
• Conduct deep therapeutic area landscape analyses; identify and articulate differentiation strategies, target product profile vulnerabilities, emerging threats, and whitespace opportunities.
• Integrate primary expert intelligence, secondary data, field insights, and foresight outputs into unified, coherent, decision-ready products tailored for use in governance forums and TA decision-making.
• Lead competitor intent and early signal analyses to anticipate pipeline prioritization, launch strategies, lifecycle management decisions, and business development intent ahead of public disclosure.
• Provide timely insights on competitor clinical trial design, site strategy, patient enrollment, and regulatory engagement to inform BMS program and TA strategies.
• Lead enterprise conference intelligence across major medical, scientific, and commercial congresses, translating real-time signals into implications for pipeline, portfolio prioritization, and competitive positioning.
• Oversee peer-company monitoring (including quarterly earnings), assessing strategic intent, R&D prioritization shifts, capital allocation signals, and implications for BMS.
• Develop dashboards, briefing materials, and decision memos that support Leadership Team, Investor Relations, and Board engagements.
• Ensure CI outputs include a clear “so what” and explicit options/tradeoffs tailored to TA leadership, GPTs, and governance forums.
• Build and operationalize a structured strategic foresight capability, including scenario planning, horizon scanning, and signal detection across science, technology, regulation, and the competitive environment.
• Define and deliver an AI-first CI strategy that accelerates collection, monitoring, synthesis, and insight generation through advanced analytics, machine learning, and generative AI.
• Oversee the development and scaling of next-generation CI capabilities (e.g., automated landscape monitoring, competitor-intent models, and scenario generation).
• Establish enterprise-wide methodologies, tools, platforms, and processes that enable efficient intelligence sharing and knowledge management.
• Ensure CI activities and primary research are conducted in full compliance with BMS ethical standards, PhRMA guidelines, IP protection policies, and the Code of Business Conduct, in partnership with CI Operations, Legal, and Compliance.
• Partner with Portfolio Strategy, TA Leadership Teams, GPTs, and leaders across R&D, Commercial, Medical Affairs, Market Access, Business Development, Corporate Strategy, Finance, and Legal to embed intelligence into critical decision processes.
• Act as a strategic partner to global brand and asset teams, supporting launch readiness, lifecycle management, and portfolio prioritization.
• Build, lead, and develop a high-performing, globally distributed CI & foresight organization with clear roles, ways of working, and development pathways.
• Foster a culture of analytical rigor, intellectual curiosity, and continuous improvement; coach and develop talent through targeted capability-building.
• Own budget management and cultivate innovative external partnerships to extend reach and impact.

Benefits

• Health Coverage: Medical, pharmacy, dental, and vision care.
• Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
• Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
• Work-life benefits include: Paid Time Off US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
• Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
• Based on eligibility, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
• All global employees full and part-time who are actively employed at and paid directly by BMS at the end of the calendar year are eligible to take advantage of the Global Shutdown.

What This Job Offers

• Job Type: Full-time
• Career Level: Executive